🇺🇸 FDA
Patent

US 8697856

Plasmodium vivax hybrid circumsporozoite protein and vaccine

granted A61KA61K2039/55566A61K39/015

Quick answer

US patent 8697856 (Plasmodium vivax hybrid circumsporozoite protein and vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55566, A61K39/015, A61P, A61P33/02